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Molecular analysis of a small hemizygous deletion in a
patient with partial Williams syndrome suggests that
loss of the LIM-Kinase1 gene may be responsible for
the impaired visuospatial constructive cognition
characteristic of the syndrome.
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When more than one gene is removed from a chromosome
region by deletion, a complex phenotype, or ‘contiguous
gene deletion syndrome’, can result [1]. In many cases, the
deleted region spans megabases of chromosomal DNA, so
the analysis of DNA isolated from rare patients with smaller
deletions or point mutations has been very helpful in
attempts to identify the individual genes whose mutations
contribute to the syndrome. In addition, analysis of smaller
deletions helps in determining the order of genes along the
chromosome. Recently, insights into Williams syndrome, a
contiguous gene deletion syndrome of chromosome
7q11.23, were provided by the analysis of two families that
have small hemizygous deletions, one of which is only
84 kilobases [2]; most Williams syndrome patients have
deletions spanning greater than 500 kilobases.
Patients with Williams syndrome exhibit a range of
phenotypes, most notable of which are supravalvular aortic
stenosis (SVAS), a specific cognitive profile, mental retar-
dation/developmental delay, typical ‘elfin’ facial features,
idiopathic infantile hypercalcemia and inguinal hernia [3].
The main clinical feature of SVAS is narrowing of the
large elastic arteries, which compromises blood flow. The
specific cognitive profile in Williams syndrome includes
pronounced auditory and language rote memory, a gregari-
ous personality and impaired visuospatial constructive
cognition — an inability to see objects or pictures as being
made up of separate parts and therefore to reconstruct
objects when presented with their individual parts. 
The elastin gene was one of the first to be identified as
deleted from one chromosome in DNA isolated from
patients with Williams syndrome. SVAS can be inherited
as a distinct autosomal dominant trait, and a translocation
break-point and a 30 kilobase deletion in the elastin gene
on chromosome 7q11 were found in patients with SVAS
who did not have the other phenotypic traits common to
Williams syndrome [4,5]. This directly implicated the
elastin gene in SVAS, and because over 75 % of Williams
syndrome patients have SVAS, it was a good candidate
gene to be tested for rearrangement or deletion in
Williams syndrome. A major breakthrough was reported in
1993 by Ewart et al. [6], who showed that the elastin gene
was missing from one chromosome (that is, it was hemizy-
gous) in both familial and sporadic cases of Williams syn-
drome. Further studies showed that over 90 % of people
with Williams syndrome had a deletion of one copy of the
elastin gene [7,8]. This suggested that hemizygous dele-
tion of the elastin gene may be responsible for the vascular
and connective tissue pathology of the Williams syndrome
phenotype, including SVAS, inguinal hernias, premature
aging of the skin and some of the facial dysmorphic fea-
tures. However, as none of the patients with a diagnosis of
solely SVAS had neurodevelopmental abnormalities, the
specific cognitive profile and general mental retardation
seen in Williams syndrome could not be easily explained
by hemizygous deletion of the elastin gene. So, the hunt
continued for other genes in the vicinity of the elastin
gene that could be involved in the neural defects seen in
Williams syndrome.
The search for candidate genes was guided by two mouse
models involving the knockout of protein kinase genes.
One was a mouse mutant in the nonreceptor tyrosine
kinase fyn [9], and the second was a ‘knockout’ of the g
subtype of the calcium- and phospholipid-dependent
protein kinase C (PKCg) [10,11]. Both murine gene dis-
ruptions reduced long-term potentiation (LTP), a cellular
phenomenon that is thought to be involved in synaptic
plasticity of neurons in the hippocampus, and hence in
memory. Moreover, the mice with reduced LTP also had
impaired spatial learning, strengthening the functional
link between LTP and learning and memory. As both of
the genes disrupted in the mouse models were protein
kinases, the University of Utah group who were hunting
for candidate genes for the cognitive aspects of Williams
syndrome tested genomic DNA in the vicinity of the
elastin gene for genes encoding conserved tyrosine kinase
domains [2]. They used the polymerase chain reaction
(PCR) to amplify a 315 base-pair sequence from a cosmid
adjacent to the elastin gene, and so identified an open
reading frame 100 % identical to part of the LIM-Kinase1
(LIMK1) gene. LIMK1 has a protein kinase domain and
also has LIM-type putative zinc-binding domains, which
have been found in a number of developmentally impor-
tant genes (such as lin-11, Isl-1 and mec-3, which give the
domain its name) [12,13]. A full-length LIMK1 cDNA
clone was mapped to the region affected in the hemizy-
gous deletions seen in Williams syndrome patients,
adjacent to the elastin gene on chromosome 7q11.23.
The next piece of the puzzle was supplied by careful
analysis of families with Williams syndrome, which
allowed identification of rare cases which did not exhibit
all of the typical phenotypic characteristics. Two families
were identified [2] with ‘partial Williams syndrome’,
which includes SVAS and the specific cognitive profile of
impaired visuospatial constructive cognition, but not the
characteristic facial features, hypercalcemia or mental
retardation. Further molecular analysis revealed that DNA
from members of these two families had hemizygous dele-
tions of about 300 kilobases and 84 kilobases, respectively.
The 300 kilobase deletion removed both the elastin and
LIMK1 genes, whereas the 84 kilobase deletion removed
only the 3′ end of the elastin gene and the complete
LIMK1 gene (Fig. 1). To ensure that no other genes
mapped to the deleted region, the Utah group sequenced
the genomic DNA contained within the 84 kilobase dele-
tion and found no evidence for any other transcribed
sequences [2]. This suggested that the specific visuospa-
tial constructive cognitive deficit seen in Williams syn-
drome could be due to the hemizygous deletion of the
LIMK1 gene, whereas the SVAS and connective tissue
pathology was due to deletion of the elastin gene (Fig. 1).
Furthermore, they checked the expression of the elastin
gene by Northern blot analysis, which revealed little or
negligible expression in fetal and adult brain yet strong
expression in adult heart and pancreas and in fetal lung.
The LIMK1 gene was found to be expressed ubiquitously
in all fetal and adult tissues, with the highest level in
brain. In situ hybridization analysis of LIMK1 in human
embryos showed expression in the developing brain. 
The evidence overall is strong for the role of elastin in
SVAS and the connective tissue pathology seen in Williams
syndrome, especially as there are patients with only SVAS
who have specific disruptions of elastin gene sequences.
The role of the LIMK1 gene in the visuospatial construc-
tive cognitive defect seen in Williams syndrome is at this
stage suggestive but not decisive. Deletions and other
chromosomal rearrangements can cause position effects on
the expression of genes whose coding sequences are quite
distant from the deleted region (up to hundreds of kilo-
bases away); these effects can be due to several causes, one
of which is the removal of locus control regions that exert
long-distance control of expression and chromatin domains
(see [14] for review). All of the current evidence for the role
of LIMK1 in the cognitive defect seen in Williams syn-
drome is based on the analysis of one patient with an
84 kilobase deletion, and the correlated findings that
removal of two different protein kinases in mice disrupted
spatial learning. More deletion break-points are needed to
determine the precise critical interval for the specific cog-
nitive profile in Williams syndrome. This may be difficult
to achieve, however, as most patients have deletions
greater than 500 kilobases and the Utah group screened
hundreds of patients to identify the two families with
partial Williams syndrome. 
A complete transcript map of the region surrounding the
elastin and LIMK1 genes also needs to be completed, to
see whether there are other genes that could be involved
by a position effect. Also, there are several examples of
syndromes in which double deletions or deletions coupled
to chromosomal inversions have occurred, thereby giving
false information on the location of the critical interval for
a specific disease. A complete physical and transcript map
of the Williams syndrome region would provide more
information on the possibility of a complex rearrangement
in the family segregating the 84 kilobase deletion. It
would also provide more genes as candidates for the other
features of the full Williams syndrome phenotype (includ-
ing characteristic facial features, hypercalcemia and
mental retardation/developmental delay; see Fig. 1).
Mutations which specifically disrupt the LIMK1 gene in
patients with visuospatial constructive cognitive defect
would be the most compelling evidence, but patients with
these specific deficits will be difficult to find. Mouse
models for disruption of the LIMK1 gene will also be
essential for determining its role in neural development
and spatial learning. But we have already been presented
with an important and exciting dissection of the Williams
syndrome phenotype, which has important implications




Schematic diagram of the small region of chromosome 7q11 deleted
in Williams syndrome. The genes for elastin and LIM-Kinase1 are
indicated, as well as the limits of the 84 kilobase hemizygous deletion
detected in one family with partial Williams syndrome (see text for
details). The locations of other unidentified genes for the remaining
features of Williams syndrome are shown as potentially adjacent to the
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are greater than 500 kilobases
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